目的:本范围综述探讨了半面微瘤(HFM)患者进行性面部不对称(FA)中下颌骨的各种参数,强调它与性的关系,人口,和年龄组。
方法:该评论基于对PubMed的全面搜索,EBSCOhost,和WebofScience。符合纳入标准的合格研究构成选择研究的一部分。使用混合方法评估工具的筛选和定量标准对纳入的研究进行评估。作者利用预先设定的数据提取表格从纳入的研究中获取信息。
结果:11项研究符合纳入标准。使用的下颌骨参数是角度测量,下巴点,Ramal高度,身体长度,和总长度。在纳入的研究中,HFM患者的FA与性别之间没有关系。大多数研究由欧洲参与者组成(55%),其次是美国人(36%)和中国人(9%)。所选研究中包括的年龄组被归类为牙列年龄(18%),儿童早至中期(18%),和不同的年龄(64%)。本综述中提供的数据仅与HFM患者患侧记录的异常特征有关。本审查中没有记录伴随的对照数据。
结论:对纳入研究的评估显示,HFM的FA不随年龄增加。因此,FA在HFM患者中是非进行性的。该信息与HFM患者的诊断和管理有关。需要更多关于HFM患者FA进展的报告。
OBJECTIVE: This scoping review explores various parameters of the mandible in progressive facial asymmetry (FA) in hemifacial microsomia (HFM) patients, highlighting its relationship with sex, population, and age group.
METHODS: The review was based on a comprehensive search of PubMed, EBSCOhost, and Web of Science. Eligible studies that met the inclusion criteria form part of the selection study. The included studies were appraised using screening and quantitative criteria of mixed-method appraisal tools. The authors utilised a pre-set data extraction form to obtain information from the included studies.
RESULTS: Eleven studies met the inclusion criteria. The mandible parameters used were angular measurements, chin point, ramal height, body length, and total length. There was no relationship between FA and sex in HFM patients in the included studies. Most of the studies were comprised of European participants (55%), followed by Americans (36%) and Chinese (9%). The age groups included in the selected studies were categorised as dentition age (18%), early-to-middle childhood (18%), and varied ages (64%). The data presented in this review only pertains to the anomalous characteristics recorded on the affected side in HFM patients. No concomitant control data was recorded in this review.
CONCLUSIONS: An assessment of the included studies revealed that FA does not increase with age in HFM. Hence, FA is non-progressive in HFM patients. This information is relevant to diagnosing and managing HFM patients. More reports are needed on the progression of FA in HFM patients.